 |
Viatris
VTRS
|
$ 12.31
|
14.9 B
|
$ 172 M
|
-4.3
|
1.0
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 9.78
|
6.04 B
|
$ -105 M
|
-9.0
|
7.8
|
$ -1.1
|
 |
 |
Bausch Health Companies
BHC
|
$ 7.17
|
2.62 B
|
$ 3.23 B
|
-6.5
|
0.3
|
$ -1.1
|
 |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.59
|
2.05 B
|
$ -71.4 M
|
-179.8
|
8.3
|
$ -0.1
|
 |
 |
Perrigo Company plc
PRGO
|
$ 13.81
|
1.9 B
|
$ 579 M
|
-65.5
|
0.4
|
$ -0.2
|
 |
 |
Harrow Health
HROW
|
$ 49.99
|
1.63 B
|
$ 17.6 M
|
-111.5
|
7.0
|
$ -0.4
|
 |
 |
Cronos Group
CRON
|
$ 2.68
|
1.44 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Pacira BioSciences
PCRX
|
$ 26.45
|
1.22 B
|
$ -75.6 M
|
-8.7
|
1.7
|
$ -3.0
|
 |
 |
Assertio Holdings
ASRT
|
$ 10.08
|
716 M
|
$ -3.27 M
|
-3.0
|
0.4
|
$ -0.2
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 5.27
|
694 M
|
$ 2.42 M
|
-83.9
|
1.7
|
$ -0.1
|
 |
 |
Emergent BioSolutions
EBS
|
$ 12.33
|
631 M
|
$ -238 M
|
-1.7
|
0.6
|
$ -7.5
|
 |
 |
Evolus
EOLS
|
$ 6.77
|
420 M
|
$ -48.4 M
|
-6.2
|
1.6
|
$ -1.1
|
 |
 |
Veru
VERU
|
$ 2.3
|
310 M
|
$ -36.3 M
|
-1.7
|
23.3
|
$ -1.4
|
 |
 |
Solid Biosciences
SLDB
|
$ 5.86
|
239 M
|
$ -115 M
|
-2.6
|
12.2
|
$ -2.3
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 4.48
|
135 M
|
$ -165 M
|
-2.4
|
-129.3
|
$ -1.9
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.09
|
57.5 M
|
$ 1.01 M
|
-20.0
|
1.5
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 0.58
|
27.8 M
|
$ -72.9 M
|
-1.2
|
11.0
|
$ -0.5
|
 |
 |
China Pharma Holdings
CPHI
|
$ 1.22
|
21.3 M
|
$ -1.98 M
|
-1.1
|
5.7
|
$ -1.2
|
 |
 |
Rockwell Medical
RMTI
|
$ 0.83
|
19.4 M
|
$ 1.12 M
|
-20.2
|
0.2
|
$ -0.0
|
 |
 |
TherapeuticsMD
TXMD
|
$ 1.73
|
18.1 M
|
$ -3.18 M
|
-34.0
|
6.6
|
$ -0.0
|
 |
 |
ProPhase Labs
PRPH
|
$ 0.52
|
8.24 M
|
$ -14.1 M
|
-1.2
|
2.0
|
$ -0.5
|
 |
 |
cbdMD
YCBD
|
$ 1.69
|
7.29 M
|
$ -1.2 M
|
-0.1
|
0.4
|
$ -11.3
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.55
|
4.41 M
|
$ -5.22 M
|
-1.6
|
0.3
|
$ -2.3
|
 |